Rallybio Corp
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 234 CHURCH STREET, NEW HAVEN, CT, 06510
Mailing Address 234 CHURCH STREET, NEW HAVEN, CT, 06510
Phone 203- 859-3820
Fiscal Year End 1231
EIN 851083789
Financial Overview
FY2024
$115.62M
Total Assets
$9.44M
Total Liabilities
$24.49M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 2, 2026 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 6, 2025 | View on SEC |
| 8-K Current report of material events | August 29, 2025 | View on SEC |
| 8-K Current report of material events | August 7, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 7, 2025 | View on SEC |
| 8-K Current report of material events | July 8, 2025 | View on SEC |
| 8-K Current report of material events | June 27, 2025 | View on SEC |
| 8-K Current report of material events | May 16, 2025 | View on SEC |
Material Events
8-K Strategy Change January 29, 2026
High Impact
- Aims to boost stock price per share to meet crucial NASDAQ listing requirements.
- Seeks to make the stock more attractive to a broader range of investors, especially institutional funds.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.